349 related articles for article (PubMed ID: 28240787)
81. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.
Zhou H; Fu R; Wang H; Zhou F; Li H; Zhou Z; Zhang L; Yang R
Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151
[TBL] [Abstract][Full Text] [Related]
82. Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation.
Qu M; Liu Q; Zhao HG; Peng J; Ni H; Hou M; Jansen AJG
Ann Hematol; 2018 Sep; 97(9):1701-1706. PubMed ID: 29777278
[TBL] [Abstract][Full Text] [Related]
83. Treatment of patients with immune thrombocytopenia admitted to the emergency room.
Bavunoğlu I; Eşkazan AE; Ar MC; Cengiz M; Yavuzer S; Salihoğlu A; Öngören Ş; Tunçkale A; Soysal T
Int J Hematol; 2016 Aug; 104(2):216-22. PubMed ID: 27129318
[TBL] [Abstract][Full Text] [Related]
84. Chronic immune thrombocytopenia in children: epidemiology and clinical presentation.
Bennett CM; Tarantino M
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1223-38. PubMed ID: 19932430
[TBL] [Abstract][Full Text] [Related]
85. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
Papagianni A; Economou M; Tragiannidis A; Karatza E; Tsatra I; Gombakis N; Athanassiadou-Piperopoulou F; Athanasiou-Metaxa M
J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022
[TBL] [Abstract][Full Text] [Related]
86. [Secondary ITP in adults].
Michel M; Lega JC; Terriou L
Rev Med Interne; 2021 Jan; 42(1):50-57. PubMed ID: 33139079
[TBL] [Abstract][Full Text] [Related]
87. [Diagnosis and therapy of idiopathic thrombocytopenic purpura (ITP) in adults].
Chrobák L
Vnitr Lek; 2002 Aug; 48(8):773-80. PubMed ID: 12425210
[TBL] [Abstract][Full Text] [Related]
88. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
89. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
90. Secondary immune thrombocytopenia in children: Characteristics and outcome of a large cohort from two Spanish centres.
Berrueco R; Sebastián E; Solsona M; González de Pablo J; Ruiz-Llobet A; Mesegué M; Gálvez E; Sevilla J
Acta Paediatr; 2021 Jun; 110(6):1952-1958. PubMed ID: 33460494
[TBL] [Abstract][Full Text] [Related]
91. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
[TBL] [Abstract][Full Text] [Related]
92. Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: results of a prospective study.
Bruin M; Bierings M; Uiterwaal C; Révész T; Bode L; Wiesman ME; Kuijpers T; Tamminga R; de Haas M
Br J Haematol; 2004 Dec; 127(5):561-7. PubMed ID: 15566359
[TBL] [Abstract][Full Text] [Related]
93. Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.
Deshayes S; Khellaf M; Zarour A; Layese R; Fain O; Terriou L; Viallard JF; Cheze S; Graveleau J; Slama B; Audia S; Cliquennois M; Ebbo M; Le Guenno G; Salles G; Bonmati C; Teillet F; Galicier L; Lambotte O; Hot A; Lefrère F; Mahévas M; Canoui-Poitrine F; Michel M; Godeau B
Am J Hematol; 2019 Dec; 94(12):1314-1324. PubMed ID: 31489694
[TBL] [Abstract][Full Text] [Related]
94. Incidence of immune thrombocytopenia in Taiwan: a nationwide population-based study.
Hung GY; Lee CY; Yen HJ; Lin LY; Horng JL
Transfusion; 2018 Nov; 58(11):2712-2719. PubMed ID: 30311951
[TBL] [Abstract][Full Text] [Related]
95. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count.
Khellaf M; Michel M; Schaeffer A; Bierling P; Godeau B
Haematologica; 2005 Jun; 90(6):829-32. PubMed ID: 15951296
[TBL] [Abstract][Full Text] [Related]
96. Chronic idiopathic thrombocytopenic purpura: present strategy, guidelines and new insights.
Stevens W; Koene H; Zwaginga JJ; Vreugdenhil G
Neth J Med; 2006 Nov; 64(10):356-63. PubMed ID: 17122451
[TBL] [Abstract][Full Text] [Related]
97. Diagnoses, Outcomes, and Chronicity Predictors of Patients with Secondary Immune Thrombocytopenia: Ten-Year Data from a Hematology Referral Center.
Jaime-Pérez JC; Ramos-Dávila EM; Aguilar-Calderón P; Jiménez-Castillo RA; Gómez-Almaguer D
Rev Invest Clin; 2020 Oct; 73(1):031-038. PubMed ID: 33084609
[TBL] [Abstract][Full Text] [Related]
98. Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort.
Flores A; Klaassen RJ; Buchanan GR; Neunert CE
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28111877
[TBL] [Abstract][Full Text] [Related]
99. Management of major bleeds in patients with immune thrombocytopenia.
Mithoowani S; Cervi A; Shah N; Ejaz R; Sirotich E; Barty R; Li N; Nazy I; Arnold DM
J Thromb Haemost; 2020 Jul; 18(7):1783-1790. PubMed ID: 32219982
[TBL] [Abstract][Full Text] [Related]
100. Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom.
Bennett D; Hodgson ME; Shukla A; Logie JW
Adv Ther; 2011 Dec; 28(12):1096-104. PubMed ID: 22139790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
